Health ❯Medicine ❯Pharmacology

Drug Development

Cell Biology Chronic Diseases Neurological Disorders Opioid Epidemic Pancreatic Cancer Cognitive Disorders Immunotherapy Inflammation Metabolism Clinical Research

3 ARTICLES

3w ago

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

Derived from salicylate, SANA triggers a creatine-driven heat-generating cycle in fat cells as it prepares for phase 2 efficacy trials later this year

4 ARTICLES

3w ago

Disulfiram Inhibits Pyroptosis to Reduce Trauma Damage, Showing Greater Benefit in Females

5 ARTICLES

last mo.

MIT-Harvard Study Identifies New Alzheimer’s Drug Targets in RNA and DNA Pathways

5 ARTICLES

last mo.

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

4 ARTICLES

2mo ago

STAT3 Degraders Poised for Clinical Trials to Combat Immunotherapy Resistance

3 ARTICLES

2mo ago

Dual PIKfyve and KRAS-MAPK Inhibition Eradicates Pancreatic Tumors in Preclinical Models

4 ARTICLES

2mo ago

New Drug Delivery Strategy Could Transform Cancer and Neurological Treatments

3 ARTICLES

3mo ago

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%

Drug Development

Experimental Drug SANA Boosts Fat Thermogenesis to Promote Weight Loss Ahead of Phase 2 Trials

New Oral β2 Agonist Preserves Muscle in Early Weight-Loss Trials

Liraglutide Cuts Chronic Migraine Days by More Than Half

Cancer Cell Cholesterol Depletion Heightens Hyperthermia Treatment Efficacy

Disulfiram Inhibits Pyroptosis to Reduce Trauma Damage, Showing Greater Benefit in Females

MIT-Harvard Study Identifies New Alzheimer’s Drug Targets in RNA and DNA Pathways

Duke's SBI-810 Shows Promise as Non-Opioid Painkiller in Preclinical Studies

STAT3 Degraders Poised for Clinical Trials to Combat Immunotherapy Resistance

Dual PIKfyve and KRAS-MAPK Inhibition Eradicates Pancreatic Tumors in Preclinical Models

New Drug Delivery Strategy Could Transform Cancer and Neurological Treatments

Experimental Drug Shows Potential to Delay Alzheimer's Onset by 50%